Show simple item record

dc.contributor.authorAtwiine, Barnabas
dc.contributor.authorKiwanuka, Julius
dc.contributor.authorMusinguzi, Nicholas
dc.contributor.authorAtwine, Daniel
dc.contributor.authorHaberer, Jessica E.
dc.date.accessioned2022-02-02T09:26:50Z
dc.date.available2022-02-02T09:26:50Z
dc.date.issued2015
dc.identifier.citationAtwiine, B., Kiwanuka, J., Musinguzi, N., Atwine, D., & Haberer, J. E. (2015). Understanding the role of age in HIV disclosure rates and patterns for HIV-infected children in southwestern Uganda. AIDS care, 27(4), 424-430.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/1347
dc.description.abstractHighly active antiretroviral therapy has enabled HIV-infected children to survive into adolescence and adulthood, creating need for their own HIV diagnosis disclosure. Disclosure has numerous social and medical benefits for the child and family; however, disclosure rates tend to be low, especially in developing countries, and further understanding of the barriers is needed. This study describes the patterns and correlates of disclosure among HIV-infected children in southwestern Uganda. A cross-sectional study was conducted in a referral hospital pediatric HIV clinic between February and April 2012. Interviews were administered to caregivers of HIV-infected children aged 5–17 years. Data collected included socio-demographic characteristics of the child and caregiver, reported disclosure status, and caregivers’ reasons for full disclosure or non-full disclosure of HIV status to their children. Bivariate and multivariate analysis was done to establish the socio-demographic correlates of disclosure. Caregivers provided data for 307 children; the median age was eight years (interquartile range [IQR] 7–11) and 52% were males. Ninety-five (31%) children had received full disclosure (48% of whom were >12 years), 22 children (7%) had received partial disclosure, 39 (13%) misinformation, and 151 (49%) no disclosure. Full disclosure was significantly more prevalent among the 9–11 and 12- to 17-year-olds compared to 5- to 8-year-olds (p-value < 0.001). The most frequently stated reason for disclosure was the hope that disclosure would improve medication adherence; the most frequently stated reason for nondisclosure was the belief that the child was too young to understand his/her illness. There was an inverse relationship between age and full disclosure and partial disclosure was rare across all age groups, suggesting a pattern of rapid, late disclosure. Disclosure programs should emphasize the importance of gradual disclosure, starting at younger ages, to maximize the benefits to the child and caregiveren_US
dc.language.isoen_USen_US
dc.publisherAIDS careen_US
dc.subjectHIVen_US
dc.subjectAIDSen_US
dc.subjectChildrenen_US
dc.subjectDisclosureen_US
dc.subjectUgandaen_US
dc.titleUnderstanding the role of age in HIV disclosure rates and patterns for HIV-infected children in southwestern Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record